Mobeus has acquired Distant Journeys
Mobeus Equity Partners has acquired Distant Journeys. Mobeus will support co-founder and MD, Simon Whittle. With the new funding, Distant Journeys plans to enhance its offerings in established markets and aims to extend its reach with expansion into new destinations.
Mobeus is a leading equity investor in UK-based SMEs. The firm partners with talented and determined management teams of businesses with strong growth potential.
Distant Journeys is an award-winning, leading provider of long-haul escorted tours. The directors at Distant Journeys have over 80 years combined experience designing escorted touring holidays in Australia, New Zealand, India, South Africa, Canada and Alaska, Japan, Vietnam and Cambodia, Sri Lanka and China. Using its extensive knowledge, the company has created an exciting style of flexible escorted tours combining the delights and camaraderie of group travel with the flexibility to allow for individual tastes and personal interests.
Oaklins Cavendish, based in the UK, advised Mobeus, a leading equity investor in UK-based SMEs, on its management buy-out of Distant Journeys.
Chris Price
Partner, Mobeus Equity Partners
Contáctese con el equipo de la transacción
Transacciones relacionadas
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Ver másDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Ver másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Ver más